New Finnish medicines agency combines evaluation and HTA role
This article was originally published in SRA
Executive Summary
Fimea, the new Finnish medicines agency that began its operations on 2 November1,2 will carry out health technology assessments in addition to the evaluation of medicines. According to the Finnish pharma industry association, PIF, the new functions assigned to Fimea make it among the few medicines evaluation agencies to have HTA within its remit.